Scynexis (SCYX) Liabilities and Shareholders Equity (2013 - 2026)

Scynexis (SCYX) reported Liabilities and Shareholders Equity of $77.6 million for Q1 2026, up 14.3% on a YoY basis from $67.9 million in Q1 2025, and up 31.51% quarter-over-quarter from $59.0 million in Q4 2025.

Scynexis (SCYX) Liabilities and Shareholders Equity (2013 - 2026) Analysis & Trends

Scynexis has reported Liabilities and Shareholders Equity for 14 years, with the latest figure at $77.6 million in Q1 2026.

  • For the quarter ending Q1 2026, Liabilities and Shareholders Equity rose 14.3% year-over-year to $77.6 million; the trailing twelve-month figure through Mar 2026 stood at $248.4 million (down 32.02% YoY), and the FY2025 full-year result was $59.0 million, down 34.88% from the prior year.
  • Liabilities and Shareholders Equity for Q1 2026 stood at $77.6 million, up from $59.0 million in the prior quarter.
  • The five-year high for Liabilities and Shareholders Equity was $154.9 million in Q2 2023, with the low at $51.1 million in Q3 2025.
  • Historically, Liabilities and Shareholders Equity has averaged $98.9 million across 5 years, with a median of $99.0 million in 2024.
  • Annual changes were most pronounced in 2024 — Liabilities and Shareholders Equity surged 68.22% — and 2025, when it slumped 48.43%.
  • Scynexis' Liabilities and Shareholders Equity stood at $87.8 million in 2022, then soared by 46.24% to $128.4 million in 2023, then decreased by 29.41% to $90.6 million in 2024, then sank by 34.88% to $59.0 million in 2025, then jumped by 31.51% to $77.6 million in 2026.
  • The last three Liabilities and Shareholders Equity figures came in at $77.6 million (Q1 2026), $59.0 million (Q4 2025), and $51.1 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 40.04 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 15.15 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 6.71 Bn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 555.95 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 4.91 Bn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 13.22 Bn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 4.26 Bn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 2.27 Bn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 2.35 Bn
10 Scynexis 225.23 Mn 165.97 Mn - 77.63 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 77.63 Mn
Dec 31, 2025 59.03 Mn
Sep 30, 2025 51.07 Mn
Jun 30, 2025 60.69 Mn
Mar 31, 2025 67.92 Mn
Dec 31, 2024 90.64 Mn
Sep 30, 2024 99.04 Mn
Jun 30, 2024 107.81 Mn
Mar 31, 2024 118.25 Mn
Dec 31, 2023 128.41 Mn
Sep 30, 2023 148.55 Mn
Jun 30, 2023 154.86 Mn
Mar 31, 2023 70.30 Mn
Dec 31, 2022 87.81 Mn
Sep 30, 2022 112.29 Mn
Jun 30, 2022 135.61 Mn
Mar 31, 2022 111.56 Mn
Dec 31, 2021 119.84 Mn
Sep 30, 2021 109.88 Mn
Jun 30, 2021 121.13 Mn